Skip to main content
Signal8

Cresco Labs Inc. (CRLBF)

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Cresco Labs Inc. logo

Cresco Labs Inc.

OTC:CRLBFHealthcare
-5.54%$0.6000
Mkt Cap$221.59M
Float343.86M
O/S369.32M
Inst Own-
SI0.3%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$221.59M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 369.32M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateDec 3, 2018
Shares Outstanding369.32M
Float343.86M
Company Overview

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers.

It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods.

The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.

Leadership

Charles Bachtell

Co-Founder, Chief Executive Officer & Director

Gregory Butler

President

Robert Sampson

Co-Founder & Independent Director

Angie Demchenko

Chief People Officer

Employees

3K+

Country

US

Sector

Healthcare

Website

crescolabs.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
4
HOLD
3
SELL
0
TOTAL7
Insider Trading
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(5)
--
Insiderⓘ
(0)
--
5%+ Owners
(1)
--
Unattributed (incl. retail)ⓘ
Sources: 13F, 13D/13G
Insiders & Institutional Holders
52-Week Range
$0.5711$2.30
$0.6000(2nd percentile)
Volume
Average Daily Volume650.09K
213.14K today vs 650.09K avg(-67%)

30d Avg

650.09K

60d Avg

607.37K

90d Avg

558.98K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...